NeuroConX Innovation Exchange
NeuroConX brings together researchers, business leaders, clinical investigators and investment professionals to discuss the latest therapeutic approaches in the treatment of neurodegenerative diseases. Leading experts will discuss the latest scientific findings around microbiome effects in various brain disorders, including Parkinson’s disease, Alzheimer’s disease, ALS, autism, schizophrenia, and depression. Industry leaders will present ways in which innovators are harnessing the human microbiome and advancing novel therapeutics and diagnostics.
Prince Edward Island Convention Centre
4 Queen St
Charlottetown PE C1A 4A2